ReviewCancer science2025
Persist or resist: Immune checkpoint inhibitors in EGFR-mutated NSCLC.
Pengcheng Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this paperpooled itcites it
ReviewCancer science2025
Pengcheng Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.